Are BPA Substitutes as Obesogenic as BPA?

Metabolic diseases, such as obesity, Type II diabetes and hepatic steatosis, are a significant public health concern affecting more than half a billion people worldwide. The prevalence of these diseases is constantly increasing in developed countries, affecting all age groups. The pathogenesis of me...

Full description

Bibliographic Details
Main Authors: Fabiana Oliviero, Alice Marmugi, Catherine Viguié, Véronique Gayrard, Nicole Picard-Hagen, Laila Mselli-Lakhal
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/8/4238
_version_ 1797434559090917376
author Fabiana Oliviero
Alice Marmugi
Catherine Viguié
Véronique Gayrard
Nicole Picard-Hagen
Laila Mselli-Lakhal
author_facet Fabiana Oliviero
Alice Marmugi
Catherine Viguié
Véronique Gayrard
Nicole Picard-Hagen
Laila Mselli-Lakhal
author_sort Fabiana Oliviero
collection DOAJ
description Metabolic diseases, such as obesity, Type II diabetes and hepatic steatosis, are a significant public health concern affecting more than half a billion people worldwide. The prevalence of these diseases is constantly increasing in developed countries, affecting all age groups. The pathogenesis of metabolic diseases is complex and multifactorial. Inducer factors can either be genetic or linked to a sedentary lifestyle and/or consumption of high-fat and sugar diets. In 2002, a new concept of “environmental obesogens” emerged, suggesting that environmental chemicals could play an active role in the etiology of obesity. Bisphenol A (BPA), a xenoestrogen widely used in the plastic food packaging industry has been shown to affect many physiological functions and has been linked to reproductive, endocrine and metabolic disorders and cancer. Therefore, the widespread use of BPA during the last 30 years could have contributed to the increased incidence of metabolic diseases. BPA was banned in baby bottles in Canada in 2008 and in all food-oriented packaging in France from 1 January 2015. Since the BPA ban, substitutes with a similar structure and properties have been used by industrials even though their toxic potential is unknown. Bisphenol S has mainly replaced BPA in consumer products as reflected by the almost ubiquitous human exposure to this contaminant. This review focuses on the metabolic effects and targets of BPA and recent data, which suggest comparable effects of the structural analogs used as substitutes.
first_indexed 2024-03-09T10:34:03Z
format Article
id doaj.art-5d4a986479304653941524daa9c1a285
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T10:34:03Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-5d4a986479304653941524daa9c1a2852023-12-01T21:03:15ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-04-01238423810.3390/ijms23084238Are BPA Substitutes as Obesogenic as BPA?Fabiana Oliviero0Alice Marmugi1Catherine Viguié2Véronique Gayrard3Nicole Picard-Hagen4Laila Mselli-Lakhal5ToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31027 Toulouse, FranceToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31027 Toulouse, FranceToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31027 Toulouse, FranceToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31027 Toulouse, FranceToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31027 Toulouse, FranceToxAlim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31027 Toulouse, FranceMetabolic diseases, such as obesity, Type II diabetes and hepatic steatosis, are a significant public health concern affecting more than half a billion people worldwide. The prevalence of these diseases is constantly increasing in developed countries, affecting all age groups. The pathogenesis of metabolic diseases is complex and multifactorial. Inducer factors can either be genetic or linked to a sedentary lifestyle and/or consumption of high-fat and sugar diets. In 2002, a new concept of “environmental obesogens” emerged, suggesting that environmental chemicals could play an active role in the etiology of obesity. Bisphenol A (BPA), a xenoestrogen widely used in the plastic food packaging industry has been shown to affect many physiological functions and has been linked to reproductive, endocrine and metabolic disorders and cancer. Therefore, the widespread use of BPA during the last 30 years could have contributed to the increased incidence of metabolic diseases. BPA was banned in baby bottles in Canada in 2008 and in all food-oriented packaging in France from 1 January 2015. Since the BPA ban, substitutes with a similar structure and properties have been used by industrials even though their toxic potential is unknown. Bisphenol S has mainly replaced BPA in consumer products as reflected by the almost ubiquitous human exposure to this contaminant. This review focuses on the metabolic effects and targets of BPA and recent data, which suggest comparable effects of the structural analogs used as substitutes.https://www.mdpi.com/1422-0067/23/8/4238BPA substitutesmetabolic disordersendocrine disruptors
spellingShingle Fabiana Oliviero
Alice Marmugi
Catherine Viguié
Véronique Gayrard
Nicole Picard-Hagen
Laila Mselli-Lakhal
Are BPA Substitutes as Obesogenic as BPA?
International Journal of Molecular Sciences
BPA substitutes
metabolic disorders
endocrine disruptors
title Are BPA Substitutes as Obesogenic as BPA?
title_full Are BPA Substitutes as Obesogenic as BPA?
title_fullStr Are BPA Substitutes as Obesogenic as BPA?
title_full_unstemmed Are BPA Substitutes as Obesogenic as BPA?
title_short Are BPA Substitutes as Obesogenic as BPA?
title_sort are bpa substitutes as obesogenic as bpa
topic BPA substitutes
metabolic disorders
endocrine disruptors
url https://www.mdpi.com/1422-0067/23/8/4238
work_keys_str_mv AT fabianaoliviero arebpasubstitutesasobesogenicasbpa
AT alicemarmugi arebpasubstitutesasobesogenicasbpa
AT catherineviguie arebpasubstitutesasobesogenicasbpa
AT veroniquegayrard arebpasubstitutesasobesogenicasbpa
AT nicolepicardhagen arebpasubstitutesasobesogenicasbpa
AT lailamsellilakhal arebpasubstitutesasobesogenicasbpa